Caricamento...

Lu-177-Based Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors

Peptide receptor radionuclide therapy (PRRT) is a systemic cytotoxic radiation therapy using a compound of β-emitting radionuclide chelated to a peptide for the treatment of tumor with overexpressed specific cell receptor such as somatostatin receptor subtype 2 (SSTR2) of neuroendocrine tumor (NET)....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Nucl Med Mol Imaging
Autori principali: Kim, Keunyoung, Kim, Seong-Jang
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Berlin Heidelberg 2017
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5995779/
https://ncbi.nlm.nih.gov/pubmed/29942399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13139-017-0505-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !